Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neuronetics Inc.

4.49
+0.04000.90%
Post-market: 4.490.00000.00%17:57 EDT
Volume:442.66K
Turnover:1.97M
Market Cap:296.85M
PE:-3.68
High:4.53
Open:4.43
Low:4.38
Close:4.45
Loading ...

Company Profile

Company Name:
Neuronetics Inc.
Exchange:
NASDAQ
Establishment Date:
2001
Employees:
716
Office Location:
3222 Phoenixville Pike,Malvern,Pennsylvania,United States
Zip Code:
19355
Fax:
610 640 4206
Introduction:
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Directors

Name
Position
Keith J. Sullivan
Director, President and Chief Executive Officer
Robert A. Cascella
Non-Executive Chairman of the Board
Avinash N. Amin
Independent Director
Glenn Muir
Independent Director
Megan R. Rosengarten
Independent Director
Sasha S. Cucuz
Independent Director
Sheryl L. Conley
Independent Director

Shareholders

Name
Position
Keith J. Sullivan
Director, President and Chief Executive Officer
Steven Pfanstiel
Executive Vice President, Chief Financial Officer and Treasurer
W. Andrew Macan
Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary